Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 27


Risk factors and biomarkers of age-related macular degeneration.

Lambert NG, ElShelmani H, Singh MK, Mansergh FC, Wride MA, Padilla M, Keegan D, Hogg RE, Ambati BK.

Prog Retin Eye Res. 2016 Sep;54:64-102. doi: 10.1016/j.preteyeres.2016.04.003. Epub 2016 May 6. Review.


The Montrachet Study: study design, methodology and analysis of visual acuity and refractive errors in an elderly population.

Creuzot-Garcher C, Binquet C, Daniel S, Bretillon L, Acar N, de Lazzer A, Arnould L, Tzourio C, Bron AM, Delcourt C.

Acta Ophthalmol. 2016 Mar;94(2):e90-7. doi: 10.1111/aos.12842. Epub 2015 Oct 15.


CFH Y402H and ARMS2 A69S Polymorphisms and Oral Supplementation with Docosahexaenoic Acid in Neovascular Age-Related Macular Degeneration Patients: The NAT2 Study.

Merle BM, Richard F, Benlian P, Puche N, Delcourt C, Souied EH.

PLoS One. 2015 Jul 1;10(7):e0130816. doi: 10.1371/journal.pone.0130816. eCollection 2015.


Differential DNA methylation identified in the blood and retina of AMD patients.

Oliver VF, Jaffe AE, Song J, Wang G, Zhang P, Branham KE, Swaroop A, Eberhart CG, Zack DJ, Qian J, Merbs SL.

Epigenetics. 2015;10(8):698-707. doi: 10.1080/15592294.2015.1060388.


No clinically significant association between CFH and ARMS2 genotypes and response to nutritional supplements: AREDS report number 38.

Chew EY, Klein ML, Clemons TE, Agrón E, Ratnapriya R, Edwards AO, Fritsche LG, Swaroop A, Abecasis GR; Age-Related Eye Disease Study Research Group.

Ophthalmology. 2014 Nov;121(11):2173-80. doi: 10.1016/j.ophtha.2014.05.008. Epub 2014 Jun 26.


The Nakuru eye disease cohort study: methodology & rationale.

Bastawrous A, Mathenge W, Peto T, Weiss HA, Rono H, Foster A, Burton M, Kuper H.

BMC Ophthalmol. 2014 May 1;14:60. doi: 10.1186/1471-2415-14-60.


Hypomethylation of the IL17RC promoter in peripheral blood leukocytes is not a hallmark of age-related macular degeneration.

Oliver VF, Franchina M, Jaffe AE, Branham KE, Othman M, Heckenlively JR, Swaroop A, Campochiaro B, Vote BJ, Craig JE, Saffery R, Mackey DA, Qian J, Zack DJ, Hewitt AW, Merbs SL.

Cell Rep. 2013 Dec 26;5(6):1527-35. doi: 10.1016/j.celrep.2013.11.042.


Smoking and age-related macular degeneration: review and update.

Velilla S, García-Medina JJ, García-Layana A, Dolz-Marco R, Pons-Vázquez S, Pinazo-Durán MD, Gómez-Ulla F, Arévalo JF, Díaz-Llopis M, Gallego-Pinazo R.

J Ophthalmol. 2013;2013:895147. doi: 10.1155/2013/895147. Epub 2013 Dec 4. Review.


Retinal vascular caliber is associated with cardiovascular biomarkers of oxidative stress and inflammation: the POLA study.

Daien V, Carriere I, Kawasaki R, Cristol JP, Villain M, Fesler P, Ritchie K, Delcourt C.

PLoS One. 2013 Jul 26;8(7):e71089. doi: 10.1371/journal.pone.0071089. Print 2013.


Aspirin use and risk of age-related macular degeneration: a meta-analysis.

Zhu W, Wu Y, Xu D, Li YH, Jun B, Zhang XL, Wang F, Yu J.

PLoS One. 2013;8(3):e58821. doi: 10.1371/journal.pone.0058821. Epub 2013 Mar 14.


Visual impairment, optical correction, and their impact on activity limitations in elderly persons: the POLA study.

Daien V, Pérès K, Villain M, Colvez A, Delcourt C, Carrière I.

Arch Intern Med. 2011 Jul 11;171(13):1206-7. doi: 10.1001/archinternmed.2011.140. Epub 2011 Apr 11. No abstract available.


Cigarette smoke-related hydroquinone dysregulates MCP-1, VEGF and PEDF expression in retinal pigment epithelium in vitro and in vivo.

Pons M, Marin-Castaño ME.

PLoS One. 2011 Feb 28;6(2):e16722. doi: 10.1371/journal.pone.0016722.


Nicotine increases the VEGF/PEDF ratio in retinal pigment epithelium: a possible mechanism for CNV in passive smokers with AMD.

Pons M, Marin-Castaño ME.

Invest Ophthalmol Vis Sci. 2011 Jun 1;52(6):3842-53. doi: 10.1167/iovs.10-6254.


Clinical risk factors for age-related macular degeneration: a systematic review and meta-analysis.

Chakravarthy U, Wong TY, Fletcher A, Piault E, Evans C, Zlateva G, Buggage R, Pleil A, Mitchell P.

BMC Ophthalmol. 2010 Dec 13;10:31. doi: 10.1186/1471-2415-10-31. Review.


Risk factors for age-related maculopathy.

Connell PP, Keane PA, O'Neill EC, Altaie RW, Loane E, Neelam K, Nolan JM, Beatty S.

J Ophthalmol. 2009;2009:360764. doi: 10.1155/2009/360764. Epub 2009 Sep 6.


Age-related macular degeneration.

Coleman HR, Chan CC, Ferris FL 3rd, Chew EY.

Lancet. 2008 Nov 22;372(9652):1835-45. doi: 10.1016/S0140-6736(08)61759-6.


Cost-effectiveness of smoking cessation to prevent age-related macular degeneration.

Hurley SF, Matthews JP, Guymer RH.

Cost Eff Resour Alloc. 2008 Sep 11;6:18. doi: 10.1186/1478-7547-6-18.


Recurrent choroidal neovascularization after macular translocation surgery with 360-degree peripheral retinectomy.

Baer CA, Rickman CB, Srivastava S, Malek G, Stinnett S, Toth CA.

Retina. 2008 Oct;28(9):1221-7. doi: 10.1097/IAE.0b013e31817d5bce.


Biomarkers of inflammation and malnutrition associated with early death in healthy elderly people.

Carriere I, Dupuy AM, Lacroux A, Cristol JP, Delcourt C; Pathologies Oculaires Liées à l'Age Study Group.

J Am Geriatr Soc. 2008 May;56(5):840-6. doi: 10.1111/j.1532-5415.2008.01677.x. Epub 2008 Apr 9.


Associated factors for age related maculopathy in the adult population in China: the Beijing eye study.

Xu L, Li Y, Zheng Y, Jonas JB.

Br J Ophthalmol. 2006 Sep;90(9):1087-90. Epub 2006 Jun 14.

Items per page

Supplemental Content

Support Center